Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Global Health Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Developing hospitals (Lucknow, Patna) are showing strong growth with income up 28% in 9 months (excluding Noida) and margin expansion from 30% to 31.1%. Key…
5 Jul 2026
Global Health Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Developing hospitals (Lucknow, Patna, Noida) continue strong double-digit growth; revenue up ~30% YoY including Noida. Key concall takeaways from Global Health…
5 Jul 2026
Global Health Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
EBITDA and PAT showed substantial YoY growth: 23% and 50% respectively in Q1 FY26, indicating robust profitability momentum (Page 4). Key concall takeaways…
5 Jul 2026
Global Health Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
3,000 crores (Page 20). Key concall takeaways from Global Health Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
5 Jul 2026
FSN E-Commerce Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Beauty segment GMV grew 26% YoY, driven by diversified channels including e-commerce, physical retail, House of Brands, and Nykaa Superstore. Key concall…
5 Jul 2026
Vijaya Diagnostic Centre Q2 FY26: Capex ₹160 Cr | Arthneeti
Q2 FY26
guided 38%-39%. Key concall takeaways from Vijaya Diagnostic Centre Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.
5 Jul 2026
Mrs Bectors Food Specialities Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Ramp-up timelines: Indore plant reaching 50-70% utilization within 50-60 days from call date; Calcutta facility starting contributions from Q2 FY '26 but will…
5 Jul 2026
Natural Capsules Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
235-240 crores with current and upcoming capacity expansions (Page 19, 21). Key concall takeaways from Natural Capsules Ltd's Q2 FY26 earnings call — and how…
5 Jul 2026
AVP Infracon Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Current unexecuted standalone order book stands at INR 475 crores. Key concall takeaways from AVP Infracon Ltd's Q2 FY26 earnings call — and how it ranks…
5 Jul 2026
Chambal Fertilisers & Chemicals Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
CPC-SN segment has achieved 25% CAGR; plans to continue momentum with 18 new crop protection products launching in kharif and rabi. Key concall takeaways from…
5 Jul 2026
Macfos Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Maintaining or improving gross margins (~25%) is a priority despite scaling operations. Key concall takeaways from Macfos's Q2 FY26 earnings call — and how it…
5 Jul 2026
Max India Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Care at Home business to grow strategically at 20%-30% year-on-year, focusing on profitability rather than scale. Key concall takeaways from Max India Ltd's Q2…
5 Jul 2026
Fusion Finance Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Growth will be driven by both Microfinance (MFI) and MSME segments, with MSME AUM over INR710 crores ready to scale as a second growth engine. Key concall…
5 Jul 2026
AWL Agri Business Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Alternate channels (modern trade, quick commerce, e-commerce) are growing rapidly at 35-40% overall, with quick commerce specifically growing around 65%. Key…
5 Jul 2026
Star Health & Allied Insurance Company Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
For the first nine months, there was a 50% volume growth and 50% value growth; Q3 showed around 7% growth in both volume and value for Retail Health. Key…
5 Jul 2026
G R Infraprojects Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Current order book stands at approximately INR 23,700 crores. Key concall takeaways from G R Infraprojects Ltd's Q1 FY26 earnings call — and how it ranks…
5 Jul 2026
Juniper Hotels Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Focus on high-quality luxury assets with limited supply growth (<5% CAGR in luxury segment) supports premium pricing power. Key concall takeaways from Juniper…
5 Jul 2026
Juniper Hotels Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Revenue for Q2 FY26 reached a record INR235 crores, driven by 7% ARR growth across the portfolio. Key concall takeaways from Juniper Hotels Ltd's Q2 FY26…
5 Jul 2026
Juniper Hotels Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
40 crores in its first year, indicating enhancing profitability alongside revenue. Key concall takeaways from Juniper Hotels Ltd's Q1 FY26 earnings call — and…
5 Jul 2026
Juniper Hotels Q3 FY25: Revenue ₹261 Cr | Arthneeti
Q3 FY25
Q3 FY25 revenue reached ₹261 crores, up ~17% QoQ, driven by strong ARR performance at Andaz and Grand Hyatt. Key concall takeaways from Juniper Hotels Ltd's Q3…
5 Jul 2026